Molecule Details
| InChIKey | QULPHXDROMVDLR-LRDDRELGSA-N |
|---|---|
| Compound Name | (2S)-2-[(4-chlorophenyl)sulfonylcarbamoylamino]-N-[(2S)-1-oxo-1-[(2-sulfanylidene-3H-1,3,4-thiadiazol-5-yl)amino]propan-2-yl]-3-phenylpropanamide |
| Canonical SMILES | C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)NS(=O)(=O)c1ccc(Cl)cc1)C(=O)Nc1n[nH]c(=S)s1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 6.54 |
| Source | ChEMBL |
2D Structure
Activity Profile
Target Activities (3)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P22894 | MMP8 | Homo sapiens | Human | PF00045 PF00413 PF01471 | 6.7 | Ki | ChEMBL |
| P14780 | MMP9 | Homo sapiens | Human | PF00040 PF00045 PF00413 | 6.4 | Ki | ChEMBL |
| P43153 | colA | Clostridium perfringens (strain 13 / Type A) | Pathogen | PF18496 PF01752 PF08453 PF18911 PF04151 | 6.5 | Ki | ChEMBL |